Paul Parkinson, EVP Strategy and Innovation at MYRIAD GENETICS INC (MYGN), sold 11,824 shares at $25.00 ($296K) on 2021-01-08, disclosed to the SEC on 2021-01-11.
Open-market sale of $296k MYGN by EVP Strategy and Innovation. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.